Physician profile
Stephen King
NPI 1609806165
$905.28
in general payments reported to CMS, 2019-2025
17 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.38 · 2020: $16.72 · 2021: $139 · 2022: $65.35 · 2023: $108 · 2024: $212 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $199.74 | 2019-2025 | Axert |
| Bioventus LLC | $198.61 | 2022-2025 | Durolane, Gelsyn-3, Supartz Fx Sodium Hyaluronate |
| Vertex Pharmaceuticals Incorporated | $93.10 | 2025 | |
| Medical Device Business Services, INC. | $84.21 | 2021-2025 | Velys |
| Ermi LLC | $64.24 | 2024-2025 | |
| Smith+Nephew, INC. | $54.63 | 2024 | Stravix, Stravix Mesh |
| Stryker Corporation | $49.59 | 2021-2023 | N/A |
| Teleflex LLC | $21.28 | 2024 | Urolift |
| Heron Therapeutics, INC. | $19.97 | 2023 | Zynrelef |
| Solventum Corporation | $17.55 | 2024 | Spoton, Prevena, Bair Paws |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $16.72 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.10 | 2022 | |
| Abbvie INC. | $14.58 | 2022 | |
| Linvatec Corporation | $14.41 | 2023 | Biobrace 23mm |
| Fidia Pharma USA INC. | $13.79 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.61 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.